用于新冠肺炎的信使核糖核酸疫苗：简单解释 - Suppr

Suppr

超能文献

mRNA Vaccines for COVID-19: A Simple Explanation.

作者信息

Hendaus Mohamed A, Jomha Fatima A

机构信息

School of Pharmacy, Lebanese International University.

出版信息

Qatar Med J. 2021 Feb 18;2021(1):07. doi: 10.5339/qmj.2021.07. eCollection 2021.

DOI:10.5339/qmj.2021.07

PMID:33643864

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7893482/

Abstract

摘要

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3260/7893482/6066377c2f5d/qmj-2020-007-g001.jpg

相似文献

mRNA Vaccines for COVID-19: A Simple Explanation.用于新冠肺炎的信使核糖核酸疫苗：简单解释

Qatar Med J. 2021 Feb 18;2021(1):07. doi: 10.5339/qmj.2021.07. eCollection 2021.

COVID-19 mRNA vaccines (Pfizer-BioNTech and Moderna) in patients with multiple sclerosis: a statement by a working group convened by the Section of Multiple Sclerosis and Neuroimmunology of the Polish Neurological Society.新型冠状病毒肺炎（COVID-19）mRNA 疫苗（辉瑞-生物科技和 Moderna）在多发性硬化症患者中的应用：波兰神经病学会多发性硬化症和神经免疫学分会召集的工作组的一份声明。

Neurol Neurochir Pol. 2021;55(1):8-11. doi: 10.5603/PJNNS.a2021.0016. Epub 2021 Feb 8.

[Allergic reactions to COVID-19 vaccines].[对新冠病毒疫苗的过敏反应]

Ned Tijdschr Geneeskd. 2021 Feb 5;165:D5804.

A review of COVID-19 vaccines in development: 6 months into the pandemic.COVID-19 疫苗研发进展综述：大流行 6 个月后。

Pan Afr Med J. 2020 Oct 5;37:124. doi: 10.11604/pamj.2020.37.124.24973. eCollection 2020.

Frontiers in the COVID-19 vaccines development.新冠疫苗研发前沿

Exp Hematol Oncol. 2020 Sep 3;9:24. doi: 10.1186/s40164-020-00180-4. eCollection 2020.

Synthetic Messenger RNA-Based Vaccines: from Scorn to Hype.基于合成信使 RNA 的疫苗：从不屑一顾到大肆炒作。

Viruses. 2021 Feb 9;13(2):270. doi: 10.3390/v13020270.

The Century of mRNA Vaccines: COVID-19 Vaccines and Allergy.mRNA疫苗的世纪：新冠疫苗与过敏

J Investig Allergol Clin Immunol. 2021 Feb 17;31(1):89-91. doi: 10.18176/jiaci.0665. Epub 2020 Jan 4.

The BNT162b2 (BioNTech/Pfizer) vaccine had 95% efficacy against COVID-19 ≥7 days after the 2nd dose.BNT162b2（辉瑞/生物科技）疫苗在第 2 剂接种后 ≥7 天对 COVID-19 的有效率为 95%。

Ann Intern Med. 2021 Feb;174(2):JC15. doi: 10.7326/ACPJ202102160-015. Epub 2021 Feb 2.

Development of mRNA Vaccines: Scientific and Regulatory Issues.mRNA疫苗的发展：科学与监管问题。

Vaccines (Basel). 2021 Jan 23;9(2):81. doi: 10.3390/vaccines9020081.

COVID-19 and mRNA Vaccines-First Large Test for a New Approach.新冠疫情与信使核糖核酸疫苗——新方法的首次大规模试验

JAMA. 2020 Sep 22;324(12):1125-1127. doi: 10.1001/jama.2020.16866.

引用本文的文献

Impact of Maternal Exposure to SARS-CoV-2 on Immunological Components of Breast Milk.母亲感染新型冠状病毒对母乳免疫成分的影响。

Int J Mol Sci. 2025 Mar 13;26(6):2600. doi: 10.3390/ijms26062600.

A prospective observational study to evaluate the safety of COVID-19 mRNA vaccines administered to Qatar Rehabilitation Institute patients.一项前瞻性观察性研究，旨在评估向卡塔尔康复研究所患者接种新冠病毒mRNA疫苗的安全性。

Qatar Med J. 2023 Mar 1;2023(1):10. doi: 10.5339/qmj.2023.10. eCollection 2023.

Cancer vaccines: past, present and future; a review article.癌症疫苗：过去、现在与未来；一篇综述文章。

Discov Oncol. 2022 May 16;13(1):31. doi: 10.1007/s12672-022-00491-4.

Delayed inflammatory reaction to hyaluronic acid filler following Shingrix and Fluzone vaccines treated with lisinopril.在使用赖诺普利治疗的情况下，接种Shingrix和Fluzone疫苗后对透明质酸填充剂的迟发性炎症反应。

JAAD Case Rep. 2022 Apr 1;23:133-135. doi: 10.1016/j.jdcr.2022.03.018. eCollection 2022 May.

Delta variant of COVID-19: A simple explanation.新冠病毒德尔塔变异株：简要解释

Qatar Med J. 2021 Oct 5;2021(3):49. doi: 10.5339/qmj.2021.49. eCollection 2021.

From COVID-19 to Cancer mRNA Vaccines: Moving From Bench to Clinic in the Vaccine Landscape.从 COVID-19 到癌症 mRNA 疫苗：疫苗领域从实验室走向临床。

Front Immunol. 2021 Jul 7;12:679344. doi: 10.3389/fimmu.2021.679344. eCollection 2021.

本文引用的文献

Allergic Reactions Including Anaphylaxis After Receipt of the First Dose of Pfizer-BioNTech COVID-19 Vaccine - United States, December 14-23, 2020.美国 2020 年 12 月 14 日至 23 日：在接种第一剂辉瑞-BioNTech COVID-19 疫苗后出现过敏反应（包括过敏反应）。

MMWR Morb Mortal Wkly Rep. 2021 Jan 15;70(2):46-51. doi: 10.15585/mmwr.mm7002e1.

Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine.mRNA-1273 新型冠状病毒疫苗的有效性和安全性。

N Engl J Med. 2021 Feb 4;384(5):403-416. doi: 10.1056/NEJMoa2035389. Epub 2020 Dec 30.

A Review of the Progress and Challenges of Developing a Vaccine for COVID-19.《COVID-19 疫苗研发的进展与挑战综述》。

Front Immunol. 2020 Oct 14;11:585354. doi: 10.3389/fimmu.2020.585354. eCollection 2020.

Prospect of SARS-CoV-2 spike protein: Potential role in vaccine and therapeutic development.SARS-CoV-2 刺突蛋白的前景：在疫苗和治疗开发中的潜在作用。

Virus Res. 2020 Oct 15;288:198141. doi: 10.1016/j.virusres.2020.198141. Epub 2020 Aug 23.

Nanotechnology for COVID-19: Therapeutics and Vaccine Research.纳米技术在新冠病毒防治中的应用：治疗方法和疫苗研究。

ACS Nano. 2020 Jul 28;14(7):7760-7782. doi: 10.1021/acsnano.0c04006. Epub 2020 Jun 29.

Innate Immune Sensing by Cells of the Adaptive Immune System.适应性免疫系统细胞的固有免疫感应。

Front Immunol. 2020 May 29;11:1081. doi: 10.3389/fimmu.2020.01081. eCollection 2020.

The Innate Immune System: Fighting on the Front Lines or Fanning the Flames of COVID-19?先天性免疫系统：是在前线作战还是助长 COVID-19 的火势？

Cell Host Microbe. 2020 Jun 10;27(6):863-869. doi: 10.1016/j.chom.2020.05.009. Epub 2020 May 20.

Remdesivir in the treatment of coronavirus disease 2019 (COVID-19): a simplified summary.瑞德西韦治疗2019冠状病毒病（COVID-19）：简要概述。

J Biomol Struct Dyn. 2021 Jul;39(10):3787-3792. doi: 10.1080/07391102.2020.1767691. Epub 2020 May 20.

Immunological memory cells.免疫记忆细胞。

Cent Eur J Immunol. 2018;43(2):194-203. doi: 10.5114/ceji.2018.77390. Epub 2018 Jun 30.

mRNA vaccines - a new era in vaccinology.mRNA 疫苗——疫苗学的新纪元。

Nat Rev Drug Discov. 2018 Apr;17(4):261-279. doi: 10.1038/nrd.2017.243. Epub 2018 Jan 12.

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验